Insulin Resistance Plays a Significant Role in Liver Fibrosis in Chronic Hepatitis C and in the Response to Antiviral Therapy
- 1 July 2005
- journal article
- Published by Wolters Kluwer Health in American Journal of Gastroenterology
- Vol. 100 (7) , 1509-1515
- https://doi.org/10.1111/j.1572-0241.2005.41403.x
Abstract
To assess whether insulin resistance is associated with liver fibrosis in a group of patients with chronic hepatitis C virus (HCV) infection and whether there were any differences in insulin resistance between Asians and the indigenous Caucasian population. Secondly, to assess whether insulin resistance is associated with sustained virological response to antiviral therapy. We determined insulin resistance in 59 (30 Caucasians; 29 Asians) consecutive patients with HCV prior to starting antiviral therapy. Insulin resistance was measured using the homeostasis model assessment of insulin resistance (HOMA-IR). The relationship between insulin resistance and biochemical, virological, and histological data together with response to antiviral therapy was assessed. In multivariable analyses, insulin resistance as measured using the HOMA-IR model correlated positively with the stage of fibrosis, with higher degrees of insulin resistance in those with greater degrees of fibrosis (p < 0.001). This significant relationship remained even after excluding cirrhotic patients, or after adjusting for other factors associated with fibrosis in univariable analyses. Insulin resistance was significantly higher in Asians than Caucasians (p= 0.004). Around half (55.6%) of patients completing a course of antiviral treatment had a sustained virological response. Multivariable logistic regression identified HCV genotype 3, lower fasting glucose levels, and lower aspartate transaminase (AST) levels as being associated with a higher odds of a sustained virological response. After adjusting for these variables, Asian ethnicity, higher fasting insulin levels, and higher HOMA-IR levels were all associated with a poorer virological response to therapy. Insulin resistance contributes to liver fibrosis in chronic HCV infection; this relationship is not genotypic specific. Asian patients had higher insulin resistance than Caucasians. Insulin resistance is also an important predictor of sustained response to antiviral therapy.Keywords
This publication has 32 references indexed in Scilit:
- Insulin resistance is associated with chronic hepatitis C and virus infection fibrosis progressionGastroenterology, 2003
- Insulin resistance/β-cell function and serum ferritin level in non-diabetic patients with hepatitis C virus infectionLiver International, 2003
- Prevalence of Type 2 Diabetes Mellitus among Persons with Hepatitis C Virus Infection in the United StatesAnnals of Internal Medicine, 2000
- An Association between Hepatitis C Virus Infection and Type 2 Diabetes Mellitus: What Is the Connection?Annals of Internal Medicine, 2000
- Increased Risk of Type 2 Diabetes in Noncirrhotic Patients With Chronic Hepatitis C Virus InfectionMayo Clinic Proceedings, 2000
- Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas.Diabetes Care, 1999
- Global surveillance and control of hepatitis CJournal of Viral Hepatitis, 1999
- Consensus Development Conference on Insulin Resistance: 5–6 November 1997Diabetes Care, 1998
- Histological grading and staging of chronic hepatitisJournal of Hepatology, 1995
- Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic populationJournal of Hepatology, 1994